2175 related articles for article (PubMed ID: 27959277)
1. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
Ogawa R; Akaishi S
Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
[TBL] [Abstract][Full Text] [Related]
2. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
Ogawa R
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
[TBL] [Abstract][Full Text] [Related]
3. Keloids and Hypertrophic Scars Can Now Be Cured Completely: Recent Progress in Our Understanding of the Pathogenesis of Keloids and Hypertrophic Scars and the Most Promising Current Therapeutic Strategy.
Ogawa R; Akaishi S; Kuribayashi S; Miyashita T
J Nippon Med Sch; 2016; 83(2):46-53. PubMed ID: 27180789
[TBL] [Abstract][Full Text] [Related]
4. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A
Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophic and keloid scars fail to progress from the CD34
Limandjaja GC; Belien JM; Scheper RJ; Niessen FB; Gibbs S
Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605
[TBL] [Abstract][Full Text] [Related]
6. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
7. The molecular basis of keloid and hypertrophic scar formation.
Tuan TL; Nichter LS
Mol Med Today; 1998 Jan; 4(1):19-24. PubMed ID: 9494966
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hypertrophic scars and keloids with a fractional CO2 laser: a personal experience.
Scrimali L; Lomeo G; Nolfo C; Pompili G; Tamburino S; Catalani A; Siragò P; Perrotta RE
J Cosmet Laser Ther; 2010 Oct; 12(5):218-21. PubMed ID: 20825256
[TBL] [Abstract][Full Text] [Related]
9. [Hyperplastic scars and keloids. Part I: basics and prevention].
Baisch A; Riedel F
HNO; 2006 Nov; 54(11):893-904; quiz 905. PubMed ID: 17041777
[TBL] [Abstract][Full Text] [Related]
10. The link between hypertension and pathological scarring: does hypertension cause or promote keloid and hypertrophic scar pathogenesis?
Huang C; Ogawa R
Wound Repair Regen; 2014; 22(4):462-6. PubMed ID: 24899409
[TBL] [Abstract][Full Text] [Related]
11. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.
Lee HJ; Jang YJ
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498630
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Evaluation of Leptin Expression in Wound Healing: A Clue to Exuberant Scar Formation.
Seleit I; Bakry OA; Samaka RM; Tawfik AS
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):296-306. PubMed ID: 26258753
[TBL] [Abstract][Full Text] [Related]
13. Are keloid and hypertrophic scar different forms of the same disorder? A fibroproliferative skin disorder hypothesis based on keloid findings.
Huang C; Akaishi S; Hyakusoku H; Ogawa R
Int Wound J; 2014 Oct; 11(5):517-22. PubMed ID: 23173565
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Fractional CO
Tawfic SO; El-Tawdy A; Shalaby S; Foad A; Shaker O; Sayed SS; Metwally D
Lasers Surg Med; 2020 Dec; 52(10):959-965. PubMed ID: 32293045
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
[TBL] [Abstract][Full Text] [Related]
16. The treatment of hypertrophic scars and keloids.
Berman B; Flores F
Eur J Dermatol; 1998 Dec; 8(8):591-5. PubMed ID: 9889433
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell-derived endothelin-1 is involved in abnormal scar formation by dermal fibroblasts through RhoA/Rho-kinase pathway.
Kiya K; Kubo T; Kawai K; Matsuzaki S; Maeda D; Fujiwara T; Nishibayashi A; Kanazawa S; Yano K; Amano G; Katayama T; Hosokawa K
Exp Dermatol; 2017 Aug; 26(8):705-712. PubMed ID: 27892645
[TBL] [Abstract][Full Text] [Related]
18. Wnt Signaling Pathway Proteins in Scar, Hypertrophic Scar, and Keloid: Evidence for a Continuum?
Chaudet KM; Goyal A; Veprauskas KR; Nazarian RM
Am J Dermatopathol; 2020 Nov; 42(11):842-847. PubMed ID: 32310858
[TBL] [Abstract][Full Text] [Related]
19. Clinical applications of basic research that shows reducing skin tension could prevent and treat abnormal scarring: the importance of fascial/subcutaneous tensile reduction sutures and flap surgery for keloid and hypertrophic scar reconstruction.
Ogawa R; Akaishi S; Huang C; Dohi T; Aoki M; Omori Y; Koike S; Kobe K; Akimoto M; Hyakusoku H
J Nippon Med Sch; 2011; 78(2):68-76. PubMed ID: 21551963
[TBL] [Abstract][Full Text] [Related]
20. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models.
Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S
Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
